- Identify the significant MDR requirements that apply
- Benefit/Risk analysis
- Understand “Substantial Equivalence” for premarket authorization
- Highlight postmarket requirements for reports, procedures, and records
- Identify the U.S. Export consequences
EU Medical Devices Regulation: CE Mark Expiration and the EU Refusal of Your Exports
FDA and the EU have tried to harmonize device regulatory requirements for over 25 years. Major differences between the FDA and the EUincludepremarket authorization (CE Mark), complaint investigations, postmarket surveillance, and reports. The EU’s new Medical Devices Regulation (MDR) incorporates more rigorous regulatory requirements for those areas and in some cases outpaces the FDA’s requirements. The FDA gold standard may take a back seat. Corporations, manufacturers, distributors, importers and Notified Bodies now have specific requirements that must be met in order to market products with a CE mark. The requirements are more extensive than FDA’s in critical areas. This means you need to upgrade and implement your Quality System regulation program before 2020.
Webinar
Jan 01 2026, Thursday
01:00 PM EDT
60
Minutes
Intermediate Level
Code: GRC0000242
- Device Manufacturers
- Device Exports / Importers
- FDA Consultants
- Device Specification Developers
- Forensic Engineers
- Regulatory Program and Procedures Developers
- Quality Assurance Managers and Consultants
- Regulatory Affairs Directors
- International Logistics Manager (Export/Import)
- Three-year business plan developers
- Device design/specification developers
- Postmarket surveillance managers
The webinar will cover an overview of the changes in the EU’s device regulatory requirements. Compliance is required. Firms may be dismayed at the new requirements. The economic burden will be significant. A CE mark is maybe withdrawn for currently marketed devices that have predicates relying on technology for over ten years. Devices that do not meet the new CE mark requirements are subject to refusal by the foreign country and therefore do not meet the FDA’s legal requirements for export status. This means your device has no market in the EU and will not be permitted back into the U.S.
Firms need to review their FDA regulatory program to identify where some requirements may need to be revised so device design, production, CAPA and the use of a Total Product Life Cycle Paradigm conform to FDA’s and the EU’s requirements.
“The future belongs to individuals and companies who embrace the entrepreneurial spirit, whether that is inside or...
By A properly-composed JHA/AHA is one of the primary documents that large clients are increasingly asking to review in adva...
By DAN SCUNGIO
Skills-based hiring has been a topic of interest for many businesses and governments for the past few years. But even as...
By MARK SMITH